Bagherzadeh Mohammad, Aminorroaya Arya, Vafaeimanesh Jamshid, Mohajeri-Tehrani Mohammad Reza
Clinical Research Development Center, Qom University of Medical Sciences, Qom, Iran.
Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
J Med Case Rep. 2018 Aug 15;12(1):220. doi: 10.1186/s13256-018-1745-5.
Medullary thyroid carcinoma and pituitary adenoma are neuroendocrine tumors and their coexistence has not been reported in the literature, previously. Medullary thyroid carcinoma is a neoplasm of the thyroid gland arising from parafollicular c-cells producing calcitonin, and pituitary adenoma is a benign hyperplasia of the cells of the pituitary gland. Coexistence of these neoplasms can be explained by being affected by simultaneous primary neoplasms or tumor-to-tumor metastasis phenomenon.
We present the case of a 60-year-old Persian man who presented to the clinic with a chief complaint of headache for the last 2 months. His past medical history was significant for non-functional pituitary macroadenoma and medullary thyroid carcinoma and he had received a total thyroidectomy and a transsphenoidal surgery several years ago. Diagnostic evaluations revealed that the pituitary adenoma has recurred. He was well and symptom-free after the second transsphenoidal surgery for resection of the adenoma. Noticeably, investigations were negative for any form of multiple endocrine neoplasia syndromes; however, we could not rule them out definitively.
To the best of our knowledge, it is the first case reported in the literature of a patient who has been affected by recurrent non-functional pituitary adenoma and medullary thyroid carcinoma, concomitantly. Although this association can be accidental, it emphasizes the fact that patients with a history of a neoplasm should be monitored regularly in order to diagnose and treat possible second primary cancers in a timely manner. Of note, this consideration is of great importance in patients whose first neoplasms have better prognosis and survival rates, which provide them more time to develop second primary cancers, for example, pituitary adenoma.
甲状腺髓样癌和垂体腺瘤均为神经内分泌肿瘤,此前文献中尚未报道过二者并存的情况。甲状腺髓样癌是起源于分泌降钙素的甲状腺滤泡旁C细胞的肿瘤,垂体腺瘤是垂体细胞的良性增生。这些肿瘤并存可通过同时发生的原发性肿瘤或肿瘤转移现象来解释。
我们报告一例60岁的波斯男性病例,该患者因头痛为主诉就诊于诊所,头痛症状持续了2个月。他既往有非功能性垂体大腺瘤和甲状腺髓样癌病史,几年前接受了甲状腺全切术和经蝶窦手术。诊断评估显示垂体腺瘤复发。在第二次经蝶窦手术切除腺瘤后,他恢复良好且无症状。值得注意的是,各项检查均未发现任何形式的多发性内分泌肿瘤综合征;然而,我们不能完全排除这种可能性。
据我们所知,这是文献中首次报道的一例同时患有复发性非功能性垂体腺瘤和甲状腺髓样癌的患者。尽管这种关联可能是偶然的,但它强调了一个事实,即有肿瘤病史的患者应定期接受监测,以便及时诊断和治疗可能出现的第二原发性癌症。值得注意的是,对于那些首发肿瘤预后和生存率较好、从而有更多时间发展为第二原发性癌症的患者,例如垂体腺瘤患者,这种考虑尤为重要。